@article{7371b219d0db426aa54701e34336db8d,
title = "Ceftazidime-avibactam in ceftazidime-resistant infections",
author = "Yehuda Carmeli and Jon Armstrong and Paul Newell and Greg Stone and Angela Wardman",
note = "Funding Information: YC has received grants, honoraria, travel support, consulting fees, and other forms of financial support from Achaogen, Allecra Therapeutics, AstraZeneca, Basilea Pharmaceutica, Biomerieux SA, Cepheid, DaVolterra, Durata Therapeutics, Intercell AG, Merck & Co, PPD, Proteologics, Rempex Pharmaceuticals, Rib-X Pharmaceuticals, Syntezza Bioscience, Takeda Pharmaceutical Company. JA, PN, GS, and AW are employees of AstraZeneca. Medical writing support was provided by Liz Anfield, Prime Medica Ltd, Knutsford, Cheshire, UK, funded by AstraZeneca. ",
year = "2016",
doi = "10.1016/S1473-3099(16)30265-1",
language = "אנגלית",
volume = "16",
pages = "997--998",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Elsevier Ltd.",
number = "9",
}